Some workers are willing to trade vacation days or go back to the office in exchange for weight-loss drug coverage by their ...

The new weight loss drug offers promising results for those who are overweight or obese. Learn about how Zepbound works, its ...

The company created its GLP-1 Insurance Checker specifically to help you determine your coverage on popular weight loss drugs like Ozempic, Wegovy, and Zepbound. If you're new to Ro, they'll even ...

Several patients using brand-name drugs like Ozempic, Wegovy, Mounjaro, and Zepbound experienced problems with their eyes, researchers said. Seven of the nine patients their study focused on had a ...

New research supports what some people taking the blockbuster weight loss drug semaglutide – better known by the brand names Ozempic and Wegovy – have experienced: that it eases alcohol ...

Pharmaceutical companies like Novo Nordisk and Eli Lilly took the world by storm last year with a new generation of so-called GLP-1 diet products - Ozempic, Wegovy and Zepbound. The drugs were ...

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances.

The company said prescriptions for Zepbound are running at around 63,000 per week, closing the gap with Wegovy, which reached the US market two years earlier.

The active ingredient in Ozempic and Wegovy was linked to reduced cravings for drinking alcohol among people with alcohol use disorder, according to a small study published Wednesday in the ...

Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats ... tirzepatide medications like Mounjaro and Zepbound, both made by Eli Lilly.

Vision issues are rare but usually permanent Researchers point to the popularity of drugs as cause for concern Previous medications linked to vision issues have had label changes Vision issues are ...

Wegovy and Zepbound are approved for weight loss. The possible side effects of Rybelsus are similar to those of Ozempic, with nausea being the most reported adverse reaction in clinical trials.